Physical AI Daily — July 26, 2026

Johnson & Johnson receives FDA authorization for its Ottava surgical robot and prepares its first U.S. hospital deployments. Foundation partners with AMD while claiming its humanoids have already contributed to automotive production, and AgiBot begins the process of entering the public markets. Today’s episode explores physical AI’s new accountability phase—where hospitals, factories, and investors demand measurable performance rather than impressive demonstrations.